{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T14:44:06Z","timestamp":1786200246815,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Belgian Red Cross Flanders","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04561-6","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T13:39:48Z","timestamp":1756215588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of culture media supplements identifies serum components in self-reported serum-free preparations"],"prefix":"10.1186","volume":"16","author":[{"given":"Willem","family":"Delabie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Vandewalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Seghers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"De Bleser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Vandekerckhove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0052-8852","authenticated-orcid":false,"given":"Hendrik B.","family":"Feys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"issue":"1","key":"4561_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s13287-023-03589-w","volume":"14","author":"JC Fitzgerald","year":"2023","unstructured":"Fitzgerald JC, Shaw G, Murphy JM, Barry F. Media matters: culture medium-dependent hypervariable phenotype of mesenchymal stromal cells. Stem Cell Res Ther. 2023;14(1):363.","journal-title":"Stem Cell Res Ther"},{"key":"4561_CR2","doi-asserted-by":"crossref","unstructured":"Nikolits I, Nebel S, Egger D, Kre\u00df S, Kasper C. Towards physiologic culture approaches to improve standard cultivation of mesenchymal stem cells. Cells. 2021;10(4).","DOI":"10.3390\/cells10040886"},{"key":"4561_CR3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.biomaterials.2015.10.065","volume":"76","author":"T Burnouf","year":"2016","unstructured":"Burnouf T, Strunk D, Koh MB, Schallmoser K. Human platelet lysate: replacing fetal bovine serum as a gold standard for human cell propagation? Biomaterials. 2016;76:371\u201387.","journal-title":"Biomaterials"},{"issue":"1","key":"4561_CR4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/vox.12577","volume":"113","author":"D Strunk","year":"2018","unstructured":"Strunk D, Lozano M, Marks DC, Loh YS, Gstraunthaler G, Schennach H, et al. International forum on GMP-grade human platelet lysate for cell propagation. Vox Sang. 2018;113(1):e1\u201325.","journal-title":"Vox Sang"},{"issue":"5","key":"4561_CR5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s10616-013-9633-8","volume":"65","author":"G Gstraunthaler","year":"2013","unstructured":"Gstraunthaler G, van der Lindl T. A plea to reduce or replace fetal bovine serum in cell culture media. Cytotechnology. 2013;65(5):791\u20133.","journal-title":"Cytotechnology"},{"issue":"2","key":"4561_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/trf.17188","volume":"63","author":"W Delabie","year":"2023","unstructured":"Delabie W, De Bleser D, Vandewalle V, Vandekerckhove P, Compernolle V, Feys HB. Single step method for high yield human platelet lysate production. Transfusion. 2023;63(2):373\u201383.","journal-title":"Transfusion"},{"issue":"2","key":"4561_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1751-2824.2008.00195.x","volume":"3","author":"J Hardwick","year":"2008","unstructured":"Hardwick J. Blood processing. ISBT Sci Ser. 2008;3(2):148\u201376.","journal-title":"ISBT Sci Ser"},{"issue":"4","key":"4561_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/vox.12231","volume":"108","author":"B Van Aelst","year":"2015","unstructured":"Van Aelst B, Feys HB, Devloo R, Vanhoorelbeke K, Vandekerckhove P, Compernolle V. Riboflavin and Amotosalen photochemical treatments of platelet concentrates reduce thrombus formation kinetics in vitro. Vox Sang. 2015;108(4):328\u201339.","journal-title":"Vox Sang"},{"key":"4561_CR9","doi-asserted-by":"crossref","unstructured":"Hayflick L. In: Kruse PF, Patterson MK, editors. CHAPTER 3 - Subculturing human diploid fibroblast cultures. Tissue Culture: Academic; 1973. pp. 220\u20133.","DOI":"10.1016\/B978-0-12-427150-0.50060-7"},{"issue":"4","key":"4561_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8(4):315\u20137.","journal-title":"Cytotherapy"},{"issue":"7","key":"4561_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jcyt.2020.03.432","volume":"22","author":"RMT Ten Ham","year":"2020","unstructured":"Ten Ham RMT, H\u00f6vels AM, Hoekman J, Frederix GWJ, Leufkens HGM, Klungel OH, et al. What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings. Cytotherapy. 2020;22(7):388\u201397.","journal-title":"Cytotherapy"},{"key":"4561_CR12","doi-asserted-by":"crossref","unstructured":"Duarte Rojas JM, Restrepo M\u00fanera LM, Estrada Mira S. Comparison between platelet lysate, platelet lysate serum, and fetal bovine serum as supplements for cell culture, expansion, and cryopreservation. Biomedicines. 2024;12(1).","DOI":"10.3390\/biomedicines12010140"},{"key":"4561_CR13","doi-asserted-by":"crossref","unstructured":"Jakl V, Popp T, Haupt J, Port M, Roesler R, Wiese S et al. Effect of expansion media on functional characteristics of bone marrow-derived mesenchymal stromal cells. Cells. 2023;12(16).","DOI":"10.3390\/cells12162105"},{"issue":"1","key":"4561_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13287-023-03417-1","volume":"14","author":"C He","year":"2023","unstructured":"He C, Yang C, Zeng Q, Liu Z, Wang F, Chen Q, et al. Umbilical cord-derived mesenchymal stem cells cultured in the MCL medium for aplastic anemia therapy. Stem Cell Res Ther. 2023;14(1):224.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4561_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13287-022-02815-1","volume":"13","author":"S Palombella","year":"2022","unstructured":"Palombella S, Perucca Orfei C, Castellini G, Gianola S, Lopa S, Mastrogiacomo M, et al. Systematic review and meta-analysis on the use of human platelet lysate for mesenchymal stem cell cultures: comparison with fetal bovine serum and considerations on the production protocol. Stem Cell Res Ther. 2022;13(1):142.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4561_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13048-022-01081-2","volume":"15","author":"A Dadashzadeh","year":"2022","unstructured":"Dadashzadeh A, Moghassemi S, Grubliauskait\u00e9 M, Vlieghe H, Brusa D, Amorim CA. Medium supplementation can influence the human ovarian cells in vitro. J Ovarian Res. 2022;15(1):137.","journal-title":"J Ovarian Res"},{"key":"4561_CR17","doi-asserted-by":"publisher","first-page":"e13391","DOI":"10.7717\/peerj.13391","volume":"10","author":"C Aussel","year":"2022","unstructured":"Aussel C, Busson E, Vantomme H, Peltzer J, Martinaud C. Quality assessment of a serum and xenofree medium for the expansion of human GMP-grade mesenchymal stromal cells. PeerJ. 2022;10:e13391.","journal-title":"PeerJ"},{"issue":"1","key":"4561_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jcyt.2020.09.004","volume":"23","author":"VT Hoang","year":"2021","unstructured":"Hoang VT, Trinh QM, Phuong DTM, Bui HTH, Hang LM, Ngan NTH, et al. Standardized xeno- and serum-free culture platform enables large-scale expansion of high-quality mesenchymal stem\/stromal cells from perinatal and adult tissue sources. Cytotherapy. 2021;23(1):88\u201399.","journal-title":"Cytotherapy"},{"key":"4561_CR19","doi-asserted-by":"crossref","unstructured":"Lensch M, Muise A, White L, Badowski M, Harris D. Comparison of synthetic media designed for expansion of adipose-derived mesenchymal stromal cells. Biomedicines. 2018;6(2).","DOI":"10.3390\/biomedicines6020054"},{"issue":"3","key":"4561_CR20","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/stem.2280","volume":"34","author":"E Kerkela","year":"2016","unstructured":"Kerkela E, Laitinen A, Rabina J, Valkonen S, Takatalo M, Larjo A, et al. Adenosinergic immunosuppression by human mesenchymal stromal cells requires co-operation with T cells. Stem Cells. 2016;34(3):781\u201390.","journal-title":"Stem Cells"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04561-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04561-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04561-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T14:21:08Z","timestamp":1786198868000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-025-04561-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4561"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04561-6","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2023","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been updated to correct the link for ESM5.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Material was obtained from consenting healthy voluntary blood and platelet donors from the Belgian Red Cross Flanders Blood Establishment via donation procedures that follow Belgian legislation (\u2018de bloedwetgeving\u2019). The project was entitled \u2018Fundamenteel wetenschappelijk onderzoek op (rest)bloedproducten van vrijwillige bloeddonoren\u2019 approved by the Ethics Institutional Review Board named Universiteit Antwerpen Ethisch Comit\u00e9 with number 18\/24\/2089, dd 25\/06\/2018. All human body material was registered in a biobank registered with Federal Agency for Medicines and Health Products accession number (BB190034) approved by the University Hospital Institutional Review board of the University Hospital Leuven (UZ\/KU Leuven, S62549). Cells obtained from Lonza (material number PT-5006, batch number 21TL347548) were isolated from donated human tissue after obtaining permission for their use in research applications by informed consent or legal authorization.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"WD, PV and HBF are listed as inventors of pending patent applications for producing platelet lysates. All authors are employed by the Belgian Red Cross-Flanders.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"454"}}